FindTrial
Sign In

Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study

A Pilot Study Examining the Efficacy of Keppra in Acute Alcohol Related Seizure Control in the Emergency Department Setting

Status
Withdrawn
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00627133
Enrollment
0
Registered
2008-02-29
Start date
2008-02-29
Completion date
Unknown
Last updated
2018-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seizure, Alcohol Related

Keywords

Alcohol seizure

Brief summary

Pilot study to evaluate efficacy of Keppra (levetiracetam) for seizure control in patients with alcohol related seizures.

Interventions

DRUGlevetiracetam

2 gram iv load, 500mg bid

Sponsors

UCB Pharma
CollaboratorINDUSTRY
Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* No trauma * Not pregnant * No other cause for seizure (hypoglycemia, CNS causes, trauma) * Good family support * Working telephone contact

Exclusion criteria

* Pregnancy * Renal failure (creatine \> 2mg/dl * Fever or illness * Hypotension * Any trauma

Design outcomes

Primary

MeasureTime frame
Decreased seizures1, 2, 4, 8 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026